Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States

Telaprevir: a new hope in the treatment of chronic hepatitis C?

(2010) Andrew J. Fowell et al.   ADVANCES IN THERAPY

Emerging therapies for hepatitis C virus

(2010) Aybike Birerdinc et al.   EXPERT OPINION ON EMERGING DRUGS

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

(2010) M. Stepanova et al.   GUT

Telaprevir for Previously Treated Chronic HCV Infection

(2010) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus

(2009) Ivan Gentile et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

Public health impact of antiviral therapy for hepatitis C in the United States

(2009) Michael L. Volk et al.   HEPATOLOGY